Berberine clearly changes gut bacteria in people, but not always in the "good bacteria up, bad bacteria down" way that most berberine gut health claims describe. A 2026 systematic review of seven randomized trials found shifts in gut bacteria in six of them, with the most consistent pattern being fewer butyrate-producing bacteria and more Proteobacteria[1]. The authors called the changes "not uniformly favourable"[1].
The stronger human evidence is for specific uses: lowering blood sugar in type 2 diabetes, easing diarrhea-type IBS and, in one newer trial, clearing SIBO about as often as the antibiotic rifaximin[2][3][4]. Below: how berberine acts in the gut, what human trials found, the Akkermansia claims, side effects, the doses studies used and the drugs it interacts with.
Get medical help promptly if you have black, tarry or bloody stools, severe abdominal or rectal pain, frequent vomiting, signs of dehydration, or diarrhea lasting more than 2 days[5]. These need a clinician, not a supplement.
How Does Berberine Work in the Gut?
Berberine is a plant compound found in goldenseal, barberry, Oregon grape and other plants long used in Ayurvedic and Chinese medicine, including for digestive problems[6]. Because it is poorly absorbed, much of what it does seems to happen inside the intestine, in contact with gut bacteria[7]. Trial authors describe it as a bacteriostatic agent, meaning it slows bacterial growth, and these antimicrobial properties help explain why berberine supplementation can reshape the gut microbiome[2].
The relationship runs both ways:
- Bacteria change berberine. In animal studies, bacterial nitroreductase enzymes convert berberine into dihydroberberine, which is absorbed about five times better; antibiotics reduced this conversion, blood levels and berberine's lipid- and glucose-lowering effect[7].
- Berberine changes bile acid processing. In the 409-person PREMOTE trial, berberine lowered bacterial genes that turn bile acids into secondary bile acids, and lower blood deoxycholic acid tracked with better HbA1c[2].
- Berberine may alter fermentation. In rodents, oral berberine increased butyrate production by gut bacteria, and pre-treating the animals with antibiotics abolished that effect[8].
That last point is where animal and human data part ways, as the next section shows.
Does Berberine Affect Gut Bacteria? What Human Trials Show
Yes, and fairly strongly. In PREMOTE, 78 bacterial species changed with berberine but not with placebo or probiotics alone[2]. The direction is not what most supplement marketing suggests:
| Trial | Who | Berberine dose | Main gut bacteria findings |
|---|---|---|---|
| Zhang 2020 (PREMOTE)[2] | 409 adults, new type 2 diabetes, 12 weeks | 0.6 g twice daily | Fewer Faecalibacterium prausnitzii, Ruminococcus bromii, Roseburia and Bifidobacterium; more Bacteroides and gamma-Proteobacteria |
| Ming 2021[9] | 300 adults, new high blood sugar, 16 weeks | 0.5 g twice daily | Less Roseburia, more Blautia; Proteobacteria including Klebsiella pneumoniae rose with berberine alone |
| Colorectal adenoma trial, in Candrea 2026[1] | Adults after polyp removal, over 1 year | 0.6 g/day | Less Akkermansia muciniphila and Roseburia than placebo |
| Candrea 2026 review[1] | 7 randomized trials, all in China | 0.1 to 1.2 g/day | Diversity rose in 1 trial, fell in 1 and was unchanged in 4 |
Does berberine kill good gut bacteria?
It reduced several bacteria usually counted as beneficial. In PREMOTE, berberine depleted Faecalibacterium prausnitzii, Ruminococcus bromii, Roseburia species and Bifidobacterium species, all fiber fermenters that produce short-chain fatty acids[2]. In lab tests, berberine inhibited R. bromii growth at concentrations as low as 25 micrograms per milliliter[2].
The same changes may partly explain how it works. The researchers linked the loss of R. bromii to reduced bile acid conversion and better blood sugar, and they noted that metformin causes similar shifts toward Proteobacteria[2]. Whether these shifts matter for long-term gut health has not been tested; the 2026 review calls the human findings "hypothesis-generating"[1].
Should you take berberine with probiotics?
The two trials that tested the pairing found mixed results. In PREMOTE, adding a probiotic did not improve HbA1c beyond berberine alone overall[2]. In the Ming trial, only the berberine plus Bifidobacterium group lowered HbA1c versus placebo, and the rise in Proteobacteria and Klebsiella pneumoniae seen with berberine alone did not appear with the combination[9].
Does Berberine Increase Akkermansia?
In mice, yes; in people, the evidence so far points the other way. Berberine raised Akkermansia in mice in a dose- and time-dependent way, but not when the bacteria were grown with berberine in a dish, which suggests it acts through the host[10]. Those mice made more colon mucus, the layer Akkermansia muciniphila feeds on[10].
A second mouse study, on a high-fat diet, found more Akkermansia, a thicker mucus layer, more tight-junction proteins and less blood endotoxin with berberine[11]. These are the findings behind claims that berberine helps leaky gut, and they come from animals only.
The only human Akkermansia result we found ran the other way: in a trial of people with past colon polyps, a year or more of berberine at 0.6 g a day lowered A. muciniphila compared with placebo[1]. One trial does not settle it, but it means "berberine boosts Akkermansia" is not established in people.
Berberine for SIBO: How Does It Compare With Rifaximin?
The newest trial suggests berberine may clear SIBO on breath testing about as often as rifaximin. In the open-label BRIEF-SIBO trial, 186 people completed treatment with either berberine or rifaximin[4]. Breath tests turned negative in:
- Week 2: 45% with berberine vs 51% with rifaximin[4]
- Week 6: 53% with berberine vs 44% with rifaximin[4]
Berberine met the trial's non-inferiority goal and improved bloating by week 6, while rifaximin improved bowel movement frequency[4]. Two limits matter: the results so far are a 2025 conference abstract, not a full peer-reviewed paper, and neither patients nor doctors were blinded[4].
An older study from a US gastroenterology practice found that herbal formulas, which the BRIEF-SIBO team describes as containing berberine, cleared breath tests in 46% of people versus 34% with rifaximin[12][13]. That study was not randomized, and the difference was not statistically significant[12].
How long does berberine take to clear SIBO?
BRIEF-SIBO used 400 mg twice daily for 2 weeks, with follow-up to week 6[13]. The herbal formula study treated people for 4 weeks[12]. We found no trial testing berberine for methane-dominant overgrowth specifically. For how SIBO is diagnosed and managed, see our SIBO protocol and our review of probiotics for SIBO.
Does Berberine Help IBS or Diarrhea?
For diarrhea-predominant IBS, one trial is encouraging. In 132 people with IBS-D, berberine hydrochloride at 400 mg a day for 8 weeks reduced diarrhea frequency, abdominal pain and urgency more than placebo, and it was well tolerated[3]. That trial was single-country and has not been widely replicated.
For infectious diarrhea, the evidence is older. In a 1987 trial of 165 adults, a single 400 mg dose of berberine sulfate stopped diarrhea caused by enterotoxigenic E. coli within 24 hours in 42% of people versus 20% of controls[14]. Its effect on cholera was slight, and it added nothing to the antibiotic tetracycline[14].
Is Berberine "Nature's Ozempic"?
No. The nickname comes from its effects on blood sugar and body weight, but the human data show modest effects[2][15], and we found no human trial showing it acts like GLP-1 drugs. Researchers instead point to AMP-activated protein kinase (AMPK) activation and bile acid signalling as possible pathways[1][9]. Here is what the trials found:
- Blood sugar. In PREMOTE, HbA1c fell by 0.99 percentage points with berberine versus 0.59 with placebo over 12 weeks[2]. In a 36-person pilot, berberine 0.5 g three times daily lowered blood sugar about as well as the same dose of metformin[16].
- Weight. A meta-analysis of 12 randomized trials found an average loss of 2.07 kg and a 1.08 cm smaller waist[15]. NCCIH calls the weight evidence inconclusive because many studies had a high risk of bias[6].
- Evidence quality. NCCIH rates the diabetes evidence as weak: mostly Chinese patients, wide variation in results and some poor-quality studies[17].
If you have insulin resistance or type 2 diabetes, berberine is not a replacement for prescribed treatment[17]. For the wider evidence, see our guides to blood sugar supplements and to GLP-1 probiotics.
What Are the Side Effects of Berberine Supplements?
Digestive upset is the most common of the potential side effects. NCCIH lists nausea, diarrhea, bloating and constipation, usually mild to moderate[17]. How often it happens varies by trial:
| Trial | Daily dose | Digestive side effects |
|---|---|---|
| Yin 2008[16] | Up to 1.5 g | Transient GI effects in 34.5% (20 people); no liver or kidney damage |
| Zhang 2020[2] | 1.2 g | More GI events than placebo; no change in liver or kidney function |
| Ming 2021[9] | 1 g | Abdominal discomfort 10.2% vs 7.1% on placebo |
| Chen 2020[18] | 0.6 g | Constipation 1% vs under 0.5% on placebo; no serious events over 2 years |
In PREMOTE, people with GI side effects got the same blood sugar benefit as everyone else[2].
Can berberine mess up your gut?
It can upset digestion, and it shifts gut bacteria in ways that are not all favourable: fewer butyrate producers and more Proteobacteria in diabetes trials[1]. Whether that harms gut health over years has not been tested; the diabetes trials behind these findings lasted 12 to 16 weeks[2][9]. No study we read measured "die-off" reactions.
What Not to Mix With Berberine
Berberine slows enzymes that clear many drugs from the body. In healthy men taking 300 mg three times daily for 2 weeks, it reduced the activity of CYP2D6, CYP2C9 and CYP3A4, raising blood levels of the CYP3A4 test drug midazolam by about 40%[19].
This matters in practice:
- Cyclosporine. In kidney transplant recipients, adding berberine 0.2 g three times daily raised cyclosporine levels 29.3% above those of patients not taking it[20].
- Diabetes medicines and other prescriptions. NCCIH advises anyone taking medicines to talk with a healthcare provider before starting berberine[17].
- Pregnancy, breastfeeding and infants. Berberine has been linked to a harmful buildup of bilirubin in infants, so it should not be used in pregnancy or while breastfeeding, or given to babies[17].
How Much Berberine Did Studies Use?
The trials in this article used 400 mg to 1.5 g a day, usually split into two or three doses[3][16]. NCCIH says berberine is considered safe at the doses used clinically, 200 to 1,000 mg two to three times daily[17]. These are study doses, not recommendations.
| Use studied | Dose | Length |
|---|---|---|
| IBS-D[3] | 400 mg/day, in two doses | 8 weeks |
| SIBO[13] | 400 mg twice daily | 2 weeks |
| Colon polyp recurrence[18] | 300 mg twice daily | 2 years |
| Type 2 diabetes[2] | 600 mg twice daily, before meals | 12 weeks |
| Type 2 diabetes vs metformin[16] | 500 mg three times daily | 3 months |
The trials in the 2026 review all used berberine hydrochloride[1]. Also worth knowing: in the colon polyp trial, recurrence fell from 47% to 36% with berberine, a finding tied to colorectal cancer prevention research rather than everyday gut health[18].
When to See a Doctor
Talk with a doctor right away, whether or not you take berberine, if you have[5]:
- stools that are black and tarry or contain blood or pus
- severe pain in the abdomen or rectum
- frequent vomiting or signs of dehydration, such as extreme thirst, dark urine or dizziness
- diarrhea lasting more than 2 days, a high fever, or six or more loose stools a day
Also check with your prescriber before starting berberine if you take any regular medicine, have diabetes, or are pregnant or breastfeeding[17]. New digestive symptoms that persist after starting it are worth reporting rather than pushing through.
This article is for general educational purposes and is not medical advice. Berberine is a supplement, not an approved treatment for SIBO, IBS or diabetes, and it can interact with prescription drugs. Talk to a qualified healthcare professional before taking berberine, particularly if you are pregnant, breastfeeding, immunocompromised, taking prescription medication, or managing a diagnosed condition.
Frequently Asked Questions
How long before you feel the effects of berberine?
Gut and metabolic trials ran for weeks, not days. In SIBO, breath tests turned negative in 45% of people after 2 weeks of berberine. In people with diarrhea-predominant IBS, symptom changes were measured over 8 weeks. Blood sugar trials lasted 12 to 16 weeks, although one small pilot saw fasting glucose fall from week 1. NCCIH notes that weight effects showed up mainly after more than 8 weeks at doses above 1 gram a day.
Why don't doctors like berberine?
Many clinicians are cautious rather than opposed. The main reasons are the evidence base and safety: most trials are small, short and done in China, NCCIH describes the diabetes evidence as weak with poor-quality studies, and supplements are not standardized like drugs. Berberine also slows the liver enzymes CYP3A4, CYP2D6 and CYP2C9, which can raise blood levels of other medicines. It is not considered safe in pregnancy, while breastfeeding or for infants.
What organ is berberine hard on?
The gut is where most side effects show up: nausea, cramping, bloating, diarrhea and constipation. For the liver, the data so far are reassuring: a meta-analysis of 12 trials found no change in the liver enzymes ALT and AST, and the PREMOTE and Yin trials reported normal liver and kidney function. The bigger concern is indirect: by slowing liver drug-processing enzymes, berberine can raise levels of medicines such as cyclosporine.
Is berberine effective against methane SIBO?
We did not find a trial of berberine alone in methane-dominant SIBO, now often called intestinal methanogen overgrowth. The berberine-versus-rifaximin trial measured overall breath test conversion, and the older herbal therapy study used multi-herb formulas. So there is no specific evidence either way for methane. Breath test type matters for treatment choice, so this is a question to take to the clinician who ordered your test.
Does berberine help you have bowel movements?
Not in a laxative sense. Berberine has been studied for loose stools rather than constipation: it reduced diarrhea frequency and urgency in an IBS-D trial and cut stool volume in acute E. coli diarrhea. Constipation is one of its listed side effects; it was the most common adverse event in a 2-year colon polyp trial. In the SIBO trial, rifaximin, not berberine, improved bowel movement frequency.
Which is better for weight loss, berberine or Akkermansia?
No trial has compared them head to head. For berberine, a meta-analysis of 12 randomized trials found an average weight loss of about 2.07 kg, and NCCIH calls the evidence inconclusive because many studies had a high risk of bias. Berberine is sometimes promoted as an Akkermansia booster, but that comes from mouse studies; one human trial found less Akkermansia muciniphila after a year of berberine. See our Akkermansia page for the probiotic's own evidence.
What not to do while taking berberine?
Do not start it alongside prescription medicines without checking with your prescriber or pharmacist, especially diabetes drugs, cyclosporine or other drugs processed by CYP3A4, CYP2D6 or CYP2C9. Do not take it if you are pregnant or breastfeeding, and never give it to an infant. Do not use it in place of prescribed diabetes treatment. If you are being tested for SIBO, tell your clinician you are taking it, because it acts on gut bacteria.
References
- Candrea AR, Gavrilaș LI, Frumuzachi O, Mocan A, Babotă M, Crișan G. The Integrative Role of Berberine in Gut Microbiota Modulation and Cardiometabolic Outcomes: A Systematic Review of Randomised Clinical Trials. Nutrients. 2026;18(12):1858. doi:10.3390/nu18121858 ↩
- Zhang Y, Gu Y, Ren H, et al.. Gut microbiome-related effects of berberine and probiotics on type 2 diabetes (the PREMOTE study). Nature Communications. 2020;11(1):5015. doi:10.1038/s41467-020-18414-8 ↩
- Chen C, Tao C, Liu Z, et al.. A Randomized Clinical Trial of Berberine Hydrochloride in Patients with Diarrhea-Predominant Irritable Bowel Syndrome. Phytotherapy Research. 2015;29(11):1822-1827. doi:10.1002/ptr.5475 ↩
- Gao J, Guo H, Zhu L, et al.. IDDF2025-ABS-0189 New choice for small intestinal bacterial overgrowth: an RCT comparing berberine and rifaximin. Gut. 2025;74(Suppl 3):A328-A329. doi:10.1136/gutjnl-2025-iddf.227 ↩
- National Institute of Diabetes and Digestive and Kidney Diseases. Symptoms & Causes of Diarrhea. NIDDK. 2024. Available at: https://www.niddk.nih.gov/health-information/digestive-diseases/diarrhea/symptoms-causes ↩
- National Center for Complementary and Integrative Health. Berberine and Weight Loss: What You Need To Know. NCCIH. 2023. Available at: https://www.nccih.nih.gov/health/berberine-and-weight-loss-what-you-need-to-know ↩
- Feng R, Shou JW, Zhao ZX, et al.. Transforming berberine into its intestine-absorbable form by the gut microbiota. Scientific Reports. 2015;5(1):12155. doi:10.1038/srep12155 ↩
- Wang Y, Shou JW, Li XY, et al.. Berberine-induced bioactive metabolites of the gut microbiota improve energy metabolism. Metabolism. 2017;70:72-84. doi:10.1016/j.metabol.2017.02.003 ↩
- Ming J, Yu X, Xu X, et al.. Effectiveness and safety of Bifidobacterium and berberine in human hyperglycemia and their regulatory effect on the gut microbiota: a multi-center, double-blind, randomized, parallel-controlled study. Genome Medicine. 2021;13(1):125. doi:10.1186/s13073-021-00942-7 ↩
- Dong C, Yu J, Yang Y, et al.. Berberine, a potential prebiotic to indirectly promote Akkermansia growth through stimulating gut mucin secretion. Biomedicine & Pharmacotherapy. 2021;139:111595. doi:10.1016/j.biopha.2021.111595 ↩
- Zhu L, Zhang D, Zhu H, et al.. Berberine treatment increases Akkermansia in the gut and improves high-fat diet-induced atherosclerosis in Apoe−/− mice. Atherosclerosis. 2018;268:117-126. doi:10.1016/j.atherosclerosis.2017.11.023 ↩
- Chedid V, Dhalla S, Clarke JO, et al.. Herbal Therapy is Equivalent to Rifaximin for the Treatment of Small Intestinal Bacterial Overgrowth. Global Advances in Health and Medicine. 2014;3(3):16-24. doi:10.7453/gahmj.2014.019 ↩
- Guo H, Lu S, Zhang J, et al.. Berberine and rifaximin effects on small intestinal bacterial overgrowth: Study protocol for an investigator-initiated, double-arm, open-label, randomized clinical trial (BRIEF-SIBO study). Frontiers in Pharmacology. 2023;14:1121435. doi:10.3389/fphar.2023.1121435 ↩
- Rabbani GH, Butler T, Knight J, Sanyal SC, Alam K. Randomized Controlled Trial of Berberine Sulfate Therapy for Diarrhea Due to Enterotoxigenic Escherichia coli and Vibrio cholerae. Journal of Infectious Diseases. 1987;155(5):979-984. doi:10.1093/infdis/155.5.979 ↩
- Asbaghi O, Ghanbari N, Shekari M, et al.. The effect of berberine supplementation on obesity parameters, inflammation and liver function enzymes: A systematic review and meta-analysis of randomized controlled trials. Clinical Nutrition ESPEN. 2020;38:43-49. doi:10.1016/j.clnesp.2020.04.010 ↩
- Yin J, Xing H, Ye J. Efficacy of berberine in patients with type 2 diabetes mellitus. Metabolism. 2008;57(5):712-717. doi:10.1016/j.metabol.2008.01.013 ↩
- National Center for Complementary and Integrative Health. Diabetes and Dietary Supplements: What You Need To Know. NCCIH. 2023. Available at: https://www.nccih.nih.gov/health/diabetes-and-dietary-supplements-what-you-need-to-know ↩
- Chen YX, Gao QY, Zou TH, et al.. Berberine versus placebo for the prevention of recurrence of colorectal adenoma: a multicentre, double-blinded, randomised controlled study. The Lancet Gastroenterology & Hepatology. 2020;5(3):267-275. doi:10.1016/s2468-1253(19)30409-1 ↩
- Guo Y, Chen Y, Tan ZR, Klaassen CD, Zhou HH. Repeated administration of berberine inhibits cytochromes P450 in humans. European Journal of Clinical Pharmacology. 2011;68(2):213-217. doi:10.1007/s00228-011-1108-2 ↩
- Wu X, Li Q, Xin H, Yu A, Zhong M. Effects of berberine on the blood concentration of cyclosporin A in renal transplanted recipients: clinical and pharmacokinetic study. European Journal of Clinical Pharmacology. 2005;61(8):567-572. doi:10.1007/s00228-005-0952-3 ↩